Skip to content

Journal of Experimental Pharmacology

ISSN 1179-1454

2 papers in the library · 42 citations · publishing 2021-2026

Papers

Sort Most recent Most cited

Mangiferin Mitigates Ketamine-Induced Dopaminergic and Glial Dysregulation and Modulates Nrf2 Expression in a Rat Schizophrenia-Like Model

Journal of Experimental Pharmacology April 1, 2026 V. A. Chukwu, G. Anyanwu, N. Nto et al.

Introduction Schizophrenia involves dopaminergic dysregulation, oxidative stress, and glial activation within motor–cognitive circuits. Mangiferin, a polyphenolic C-glucoside from Mangifera indica, exerts antioxidant and anti-inflammatory effects partly via modulation of nuclear factor erythroid 2–related factor 2 (Nrf2) signaling. This study evaluated whether mangiferin attenuates...

Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder

Journal of Experimental Pharmacology 2021 Giacomo Grassi, Chiara Cecchelli, Luisa Vignozzi et al. 42 citations

Treatment-resistance is a frequent condition for obsessive-compulsive disorder (OCD). Over the past decades, a lot of effort has been made to address this issue, and several augmentation strategies of serotonergic drugs have been investigated. Antidopaminergic drugs are considered the first choice as augmentation strategy for treatment-resistant OCD patients, but they seem to work only for a...